atric patients (ages 0-17 years) who required EVD placement between March 2008 and June 2014. A retrospective chart review was completed, and all imaging studies were reviewed for evidence of hemorrhage with placement and removal of the EVD. The Health Insurance Portability and Accountability Act standards for privacy of personal health information were followed.
Placement Procedure for evds
The majority of EVDs in our series were placed in the operating room with the patient in a supine position. The entry point was identified as a point just anterior to the coronal suture in the midpupillary line, usually 2.5 cm to the right of midline. The scalp was clipped, prepared, and draped in a sterile fashion, and the planned incision was infiltrated with local anesthetic. An incision (typically curvilinear in case shunting would be required in the future) was made down to the bone, and a manual twist drill was used to make a small bur hole. A durotomy was made with an 18-gauge spinal needle. When image guidance was not used, the trajectory was in the midpupillary line and halfway between the tragus and lateral canthus (typically perpendicular to the calvaria). A Bactoseal catheter (DePuy Synthes) with stylet was inserted to a depth of 3-4 cm. The stylet was removed and the catheter passed to an appropriate depth based on the size of the child's head or to 5-7 cm in those with adult-sized heads, and to a measured point approximately to the foramen of Monro based on preoperative imaging studies. The proximal catheter was then tunneled subcutaneously through a separate posterior stab incision and secured to the scalp with 3-0 nylon sutures. All EVDs were removed when the patient was able to tolerate at least 24 hours of drain clamping with stable intracranial pressure, stable ventricular size, and without clinical symptoms of intracranial hypertension.
determination of evd-related hemorrhage
For each patient, all head CT and/or MRI scans performed during the index hospitalization were evaluated for evidence of hemorrhage and were compared with the official radiology reports. The images were reviewed independently by one author (C.M.), who was blinded to the clinical outcomes. Hemorrhage related to EVD placement was defined as any new hemorrhage along the ventricular catheter tract noted on postprocedural imaging that was not present on preprocedural imaging. Any new hemorrhage noted along the prior catheter tract or within the ventricles after removal was considered hemorrhage related to EVD removal. The size of the hemorrhage was determined by measuring the maximum dimensions in x (A), y (B), and z (C) axes on axial, sagittal, and coronal head CT or MR images, and volume was calculated using the formula (A × B × C/2). 12 All records were reviewed to determine if the hemorrhage was clinically significant or asymptomatic. A hemorrhage was clinically significant if the patient had a temporally related deterioration in neurological examination findings or clinical symptoms.
statistical analysis
A t-test was performed using Prism software (GraphPad Software, Inc.) to test for differences in volume between the hemorrhages noted on EVD placement and those on removal.
results
Details regarding EVD placement are shown in Table  1 . During the designated time period, 73 EVDs were placed in 63 patients (ages 2 weeks-17 years). Indications for EVD placement included shunt infection/malfunction (21 cases), tumor (12) , hydrocephalus (18) , hemorrhage (12) , edema (4), trauma (1) , and other (5) . All but 4 EVDs were placed in the frontal location. The majority (85%) of EVDs were inserted in the operating room, and navigation was used for placement in 29 patients. One catheter had to be replaced because of accidental dislocation that occurred during transportation. No catheters in this group required replacement because of blockage.
Imaging studies were performed in 50 patients after EVD placement, and hemorrhage was noted in 5 patients (10%); 3 intraparenchymal hemorrhages and 2 epidural hematomas, 1 of which was remote from the EVD insertion site. The hemorrhage volume ranged from 0.48 cm 3 to 7.7 cm 3 . None of these patients experienced symptoms related to their hemorrhage. No seizure activity was attributed to the hemorrhages, although one patient had a preexisting seizure disorder for which they were receiving daily maintenance antiepileptics, and another patient had been started on a prophylactic antiepileptic at the time of admission.
Postremoval imaging was obtained in 32 patients. Of these, 7 patients (21.9%) had hemorrhage following EVD removal that was not present on their postplacement scan, with volumes ranging from 0.012 cm 3 to 81.5 cm
3
. Three hemorrhages were completely intraventricular, 3 were intraparenchymal, and 1 patient had both an intraparenchy- mal and an intraventricular hemorrhage. One patient had hemorrhage after both placement and removal: a remote epidural hematoma after placement and a small intraparenchymal hemorrhage after EVD removal. Four of the hemorrhages were not clinically significant, and 3 occurred in patients who were deeply sedated. An EVD was replaced in 1 patient (2 hemorrhages), whereas no additional intervention was required in the third patient. Again, no seizures were recorded in any of these patients-near the time of removal, 4 of them were receiving antiepileptics for known seizure disorders or surgical prophylaxis. On comparison of the average hemorrhage volume noted on EVD placement and removal, we found that the volume was significantly larger in the group with hemorrhage after removal (31.1 ± 38.3 cm 3 vs 2.67 ± 3.36 cm 3 ). However, this was not statistically significant (p = 0.1337) given the small number of events. Table 2 shows a comparison between the total study population, those with hemorrhage on placement, and those with hemorrhage on removal. Thrombocytopenia was recorded in 2 patients with platelet counts of 55 and 80 × 10 9 /L (range 55-998 × 10 9 /L), and platelet drips were administered during these EVD procedures. There was no history of anticoagulation use or coagulopathy in the 5 patients with hemorrhage on placement, although 1 patient had an international normalized ratio of 2.02 prior to placement. Of the 7 patients with hemorrhage noted on removal, 1 was started on a heparin drip prior to the removal and 1 patient had been on heparin prior to EVD placement. Two hemorrhages occurred in patients who had undergone bone marrow transplants. A similar comparison between those who underwent imaging after placement and/or removal is displayed in Table 3 .
discussion
We determined the incidence of hemorrhage with EVD placement and removal in the pediatric population at our institution. We report a 10% hemorrhage rate with EVD placement and a hemorrhage rate of 21.9% on EVD removal in those patients who underwent imaging (Fig. 1) . Of the identified hemorrhages, the majority were asymptomatic. To our knowledge, this is the first article published that has investigated hemorrhage with EVD removal. Although many of the hemorrhages noted after both placement and removal were small and probably not clinically significant, it is still important to recognize the risk associated with these procedures. The fact that the hemorrhages identified were probably asymptomatic is largely due to their location. Our 2 patients with the largest hemorrhages had the entire volume contained within the ventricular system. Had the location been intraparenchymal, these hemorrhages would probably have been symptomatic. Several articles have shown that premature infants with intraventricular hemorrhage and a parenchymal lesion have worse neurological outcomes compared with those without parenchymal lesions. 13, 25, 26 One must consider that similar outcomes may be associated with hemorrhages caused by EVD placement or removal, although this has not been studied. Additionally, the effect of a small hematoma may extend beyond the border of the hemorrhage itself. Forbes et al. used diffusion-weighted imaging to identify regions of perihematoma abnormalities representing areas of secondary neuronal damage. 6 In the pediatric population, it is also important to remember that these patients may require the placement and removal of multiple EVDs over their lifetime. With each procedure there is the risk of hemorrhage, and there can be an additive effect of many small hemorrhages.
In the literature reporting findings in adults, only 3 articles report hemorrhage after removal of EVDs, with the incidence ranging from 1.1% to 6.9%. 7, 14, 19 It is important to note that these articles were not investigating hemorrhage on removal and may have been less stringent in detecting such hemorrhages. As previously mentioned, there are no published rates for hemorrhage after EVD removal in the pediatric population. Of those who had imaging performed after removal, we found the incidence of hemorrhage to be 21.9%. This is similar to the incidence we found for all patients who received EVDs at our institution, which included both adult and pediatric patients.
The average hemorrhage volume on EVD removal was larger than that of the hemorrhages found after placement; however, this was not statistically significant given the small number of events. This may be due to the fact that 3 of the hemorrhages were large, with volumes greater than 50 cm 3 ; however, they were entirely confined to the intraventricular space. Coincidentally, these 3 hemorrhages oc- curred in patients who were heavily sedated and who were difficult to assess for any neurological decline.
There are several limitations of this study, including its retrospective nature and small number of patients. Because we were specifically investigating hemorrhage with EVD placement and/or removal, it is possible that we may have identified small hemorrhages, which may not have been recognized on routine examinations. Determining whether a hemorrhage is clinically significant can also be challenging because many of our patients are heavily sedated and/or have significant preexisting neurological deficits so that identifying a change temporally related to the EVD placement or removal may be difficult.
At our institution we do not have a protocol for routine imaging after EVD placement or removal; it is often based on the attending neurosurgeon's preference. Our reported incidences are in those patients in whom imaging was performed after EVD placement or removal. We are unable to account for any small hemorrhages that may have occurred in the patients who did not have imaging after placement or removal. We can assume that imaging would have been performed for any clinically significant hemorrhage, because serious adverse events will present themselves without scheduled imaging.
conclusions
There is sparse literature regarding EVD complications in the pediatric population. Hemorrhage caused by placing an EVD is a common complication noted in the literature on adults, but it is only discussed in a few pediatric articles. Removing an EVD is also associated with hemorrhage and has not been previously studied in pediatric patients. We found an incidence of 10% hemorrhage at EVD placement and a 21.9% incidence of hemorrhage on EVD removal in our study in patients who underwent subsequent imaging. Although none of the hemorrhages were of clinical significance, these data can be useful in decision making, and in discussing the risks of EVDs with a patient's family. 
